TNF-α and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo

Journal of Clinical Investigation

Volumn 118, Issue 10, 2008, Pages 3440-3452

  De Jong, Marein A W P ^a   De Witte, Lot ^a   Oudhoff, Menno J ^b   Gringhuis, Sonja I ^a   Gallay, Philippe ^c   Geijtenbeek, Teunis B H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HETERODIMER; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANDIDA ALBICANS; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EX VIVO STUDY; EXPLANT; FEMALE; GENITAL TRACT INFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; INFECTION RISK; LANGERHANS CELL; NEISSERIA GONORRHOEAE; PRIORITY JOURNAL; SKIN; T LYMPHOCYTE; VAGINA; VIRUS TRANSMISSION;

BIOPSY; CYTOKINES; DISEASE SUSCEPTIBILITY; EPITHELIAL CELLS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; JURKAT CELLS; LANGERHANS CELLS; ORGAN CULTURE TECHNIQUES; PEPTIDES; SKIN; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA; VAGINA; VIRUS REPLICATION;

EID: 55849139460     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI34721     Document Type: Article

References (55)

1. Joint United Nations Programme on HIV/AIDS and World Health Organisation 2007. 2007 AIDS epidemic update. http://www.unaids.org.
2. Royce, R.A., Sena, A., Cates, W., Jr., and Cohen, M.S. 1997. Sexual transmission of HIV. N. Engl. J. Med. 336:1072-1078.
3. Ito, A., et al. 2001. Monoclonal antibody (5F3) defining renal cell carcinoma-associated antigen disialosyl globopentaosylceramide (V3NeuAcIV6 NeuAcGb5), and distribution pattern of the antigen in tumor and normal tissues. Glycoconj. J. 18:475-485.
4. Naarding, M.A., et al. 2005. Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes. J. Clin. Invest. 115:3256-3264.
5. Munch, J., et al. 2007. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell. 131:1059-1071.
6. Fleming, D.T., and Wasserheit, J.N. 1999. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm. Infect. 75:3-17.
7. Cohen, M.S. 2004. HIV and sexually transmitted diseases: lethal synergy. Top. HIV Med. 12:104-107.
8. Hester, R.A., and Kennedy, S.B. 2003. Candida infection as a risk factor for HIV transmission. J. Womens Health (Larchmt.). 12:487-494.
9. Wasserheit, J.N. 1992. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm. Dis. 19:61-77.
10. Sheffield, J.S., Wendel, G.D., Jr., McIntire, D.D., and Norgard, M.V. 2007. Effect of genital ulcer disease on HIV-1 coreceptor expression in the female genital tract. J. Infect. Dis. 196:1509-1516.
11. +-dendritic cells and Langerhans cells in HIV-1 transmission. Trends Mol. Med. 14:12-19.
12. Kawamura, T., Kurtz, S.E., Blauvelt, A., and Shimada, S. 2005. The role of Langerhans cells in the sexual transmission of HIV. J. Dermatol. Sci. 40:147-155.
13. Patterson, B.K., et al. 2002. Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture. Am. J. Pathol. 161:867-873.
14. Spira, A.I., et al. 1996. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J. Exp. Med. 183:215-225.
15. Zhang, Z., et al. 1999. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science. 286:1353-1357.
16. de Witte, L., et al. 2007. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat. Med. 13:367-371.
17. Pope, M., et al. 1994. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell. 78:389-398.
18. Reece, J.C., et al. 1998. HIV-1 selection by epidermal dendritic cells during transmission across human skin. J. Exp. Med. 187:1623-1631.
19. Berthier-Vergnes, O., et al. 2005. TNF-alpha enhances phenotypic and functional maturation of human epidermal Langerhans cells and induces IL-12 p40 and IP-10/CXCL-10 production. FEBS Lett. 579:3660-3668.
20. van der Aar, A.M., et al. 2007. Loss of TLR2, TLR4, and TLR5 on Langerhans cells abolishes bacterial recognition. J. Immunol. 178:1986-1990.
21. Flacher, V., et al. 2006. Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Gram-positive bacteria. J. Immunol. 177:7959-7967.
22. Chesson, H.W., and Pinkerton, S.D. 2000. Sexually transmitted diseases and the increased risk for HIV transmission: implications for cost-effectiveness analyses of sexually transmitted disease prevention interventions. J. Acquir. Immune Defic. Syndr. 24:48-56.
23. Sugita, K., et al. 2007. Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving Langerhans cells and T cells in the skin. Clin. Exp. Immunol. 147:176-183.
24. Chatterji, U., et al. 2005. Naturally occurring capsid substitutions render HIV-1 cyclophilin A independent in human cells and TRIM-cyclophilin- resistant in Owl monkey cells. J. Biol. Chem. 280:40293-40300.
25. Kawamura, T., et al. 2000. Candidate microbicides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explants. J. Exp. Med. 192:1491-1500.
26. Osborn, L., Kunkel, S., and Nabel, G.J. 1989. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc. Natl. Acad. Sci. U. S. A. 86:2336-2340.
27. Matsuyama, T., et al. 1989. Enhancement of HIV replication and giant cell formation by tumor necrosis factor. AIDS Res. Hum. Retroviruses. 5:139-146.
28. Netea, M.G., Van der, G.C., Van Der Meer, J.W., and Kullberg, B.J. 2004. Recognition of fungal pathogens by Toll-like receptors. Eur. J. Clin. Microbiol. Infect. Dis. 23:672-676.
29. Fisette, P.L., Ram, S., Andersen, J.M., Guo, W., and Ingalls, R.R. 2003. The Lip lipoprotein from Neisseria gonorrhoeae stimulates cytokine release and NF-kappaB activation in epithelial cells in a Toll-like receptor 2-dependent manner. J. Biol. Chem. 278:46252-46260.
30. Romani, L., Bistoni, F., and Puccetti, P. 2002. Fungi, dendritic cells and receptors: a host perspective of fungal virulence. Trends Microbiol. 10:508-514.
31. Underhill, D.M. 2004. Toll-like receptors and microbes take aim at each other. Curr. Opin. Immunol. 16:483-487.
32. Kimber, I., and Cumberbatch, M. 1992. Stimulation of Langerhans cell migration by tumor necrosis factor alpha (TNF-alpha). J. Invest. Dermatol. 99:48S-50S.
33. Roake, J.A., et al. 1995. Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J. Exp. Med. 181:2237-2247.
34. Kawamura, T., et al. 2003. R5 HIV productively infects Langerhans cells, and infection levels are regulated by compound CCR5 polymorphisms. Proc. Natl. Acad. Sci. U. S. A. 100:8401-8406.
35. Cullen, B.R. 1991. Human immunodeficiency virus as a prototypic complex retrovirus. J. Virol. 65:1053-1056.
36. Turville, S.G., et al. 2004. Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. Blood. 103:2170-2179.
37. Wiley, R.D., and Gummuluru, S. 2006. Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection. Proc. Natl. Acad. Sci. U. S. A. 103:738-743.
38. Ganesh, L., et al. 2004. Infection of specific dendritic cells by CCR5-tropic human immunodeficiency virus type 1 promotes cell-mediated transmission of virus resistant to broadly neutralizing antibodies. J. Virol. 78:11980-11987.
39. Gupta, P., et al. 2002. Memory CD4(+) T cells are the earliest detectable human immunodeficiency virus type 1 (HIV-1)-infected cells in the female genital mucosal tissue during HIV-1 transmission in an organ culture system. J. Virol. 76:9868-9876.
40. Kawamura, T., Qualbani, M., Thomas, E.K., Orenstein, J.M., and Blauvelt, A. 2001. Low levels of productive HIV infection in Langerhans cell-like dendritic cells differentiated in the presence of TGF-beta1 and increased viral replication with CD40 ligand-induced maturation. Eur. J. Immunol. 31:360-368.
41. Fahrbach, K.M., et al. 2007. Activated CD34-derived Langerhans cells mediate transinfection with human immunodeficiency virus. J. Virol. 81:6858-6868.
42. Hoffmann, P., et al. 1988. Stimulation of human and murine adherent cells by bacterial lipoprotein and synthetic lipopeptide analogues. Immunobiology. 177:158-170.
43. Aliprantis, A.O., et al. 1999. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science. 285:736-739.
44. Ozinsky, A., et al. 2000. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc. Natl. Acad. Sci. U. S. A. 97:13766- 13771.
45. Takeda, K., Kaisho, T., and Akira, S. 2003. Toll-like receptors. Annu. Rev. Immunol. 21:335-376.
46. de Witte, L., et al. 2007. Syndecan-3 is a dendritic cell-specific attachment receptor for HIV-1. Proc. Natl. Acad. Sci. U. S. A. 104:19464-19469.
47. Thibault, S., Tardif, M.R., Barat, C., and Tremblay, M.J. 2007. TLR2 signaling renders quiescent naive and memory CD4+ T cells more susceptible to productive infection with X4 and R5 HIV-type 1. J. Immunol. 179:4357-4366.
48. Kawamura, T., et al. 2004. PSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypes. J. Virol. 78:7602-7609.
49. Arrighi, J.F., et al. 2004. Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells. J. Virol. 78:10848-10855.
50. Arrighi, J.F., et al. 2004. DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells. J. Exp. Med. 200:1279-1288.
51. Wei, X., et al. 2002. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob. Agents Chemother. 46:1896-1905.
52. Lynch, G.W., et al. 2003. CD4 is expressed by epidermal Langerhans' cells predominantly as covalent dimers. Exp. Dermatol. 12:700-711.
53. Ito, A., Handa, K., Withers, D.A., Satoh, M., and Hakomori, S. 2001. Binding specificity of siglec7 to disialogangliosides of renal cell carcinoma: possible role of disialogangliosides in tumor progression. FEBS Lett. 498:116-120.
54. Gotschlich, E.C. 1994. Genetic locus for the biosynthesis of the variable portion of Neisseria gonorrhoeae lipooligosaccharide. J. Exp. Med. 180:2181-2190.
55. Garcia-Vallejo, J.J., et al. 2004. Approach for defining endogenous reference genes in gene expression experiments. Anal. Biochem. 329:293-299.